SCHEMBL1856682

SCHEMBL1856682

Cc1sc(C)c(CCl)c1CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11338382 0.85
SCHEMBL2890316 0.81
SCHEMBL11334048 0.75
SCHEMBL11346177 0.72
SCHEMBL11340425 0.69
SCHEMBL17452191 0.69 CYP1A2 (0.34)
SCHEMBL4445015 0.67
SCHEMBL258408 0.67
SCHEMBL19118411 0.67
SCHEMBL15202664 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673890-B2 2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist JANSSEN PHARMACEUTICA NV (BE) 2014-03-18 US disclosed
US-20110105490-A1 2,3-DIHYDRO-1H-ISOINDOL-1-IMINE DERIVATIVES USEFUL AS THROMBIN PAR-1 RECEPTOR ANTAGONIST JANSSEN PHARMACEUTICA NV (BE) 2011-05-05 US disclosed
US-7851644-B2 Heterocyclic metallocenes and polymerization catalysts BASELL POLYOLEFINE GMBH (DE) 2010-12-14 US disclosed
US-7705043-B2 Substituted aminodicarboxylic acid derivatives having pharmaceutical properties BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-27 US disclosed
US-20090286945-A9 Heterocyclic metallocenes and polymerization catalysts EWEN JOHN A 2009-11-19 US disclosed
US-20090163535-A1 Substituted Heteroarylalkanoic Acids THE INSTITUES FOR PHARMACEUTICAL DISCOVERY, INC. (US) 2009-06-25 US disclosed
US-20090163535-A1 Substituted Heteroarylalkanoic Acids THE INSTITUES FOR PHARMACEUTICAL DISCOVERY, INC. (US) 2009-06-25 US disclosed
US-20090163535-A1 Substituted Heteroarylalkanoic Acids THE INSTITUES FOR PHARMACEUTICAL DISCOVERY, INC. (US) 2009-06-25 US disclosed
EP-1444228-B1 SUBSTITUTED HETEROARYLALKANOIC ACIDS AND THEIR USE AS ALDOSE REDUCTASE INHIBITORS INST FOR PHARM DISCOVERY INC (US) 2008-05-21 EP disclosed
EP-1444228-B1 SUBSTITUTED HETEROARYLALKANOIC ACIDS AND THEIR USE AS ALDOSE REDUCTASE INHIBITORS INST FOR PHARM DISCOVERY INC (US) 2008-05-21 EP disclosed
US-20030166668-A1 Substituted heteroarylalkanoic acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, INC. A CORPORATION OF THE STATE OF DELAWARE 2003-09-04 US disclosed
EP-1327636-A2 Heterocyclic metallocenes and polymerisation catalysts Basell Polyolefine GmbH (DE) 2003-07-16 EP disclosed
EP-0938491-B1 HETEROCYCLIC METALLOCENES AND POLYMERIZATION CATALYSTS BASELL POLYOLEFINE GMBH (DE) 2003-05-07 EP disclosed
WO-2002070510-A2 AMINO DICARBOXYLIC ACID DERIVATIVES WITH PHARMACEUTICAL PROPERTIES BAYER AKTIENGESELLSCHAFT (DE) 2002-09-12 WO disclosed
US-5380742-A Antagonists to a2-type adrenergic receptors SYNTHELABO (FR) 1995-01-10 US disclosed
EP-0414076-B1 Cyclic substituted (quinoline-2-yl-methoxy)phenylacetic acid derivatives BAYER AG (DE) 1994-10-12 EP disclosed
EP-0599697-A1 Pyrrole derivatives, their preparation and application in therapy SYNTHELABO (FR) 1994-06-01 EP disclosed
US-5192771-A Lipoxygenase inhibitors as antiinflammatory agents BAYER AKTIENGESELLSCHAFT (DE) 1993-03-09 US disclosed
EP-0414076-A1 Cyclic substituted (quinoline-2-yl-methoxy)phenylacetic acid derivatives BAYER AG (DE) 1991-02-27 EP disclosed
US-4152335-A CROWN COMPOUNDS, NONHYGROSCOPIC SHELL OIL COMPANY (US) 1979-05-01 US disclosed